Regulatory Affairs Outsourcing Market Analysis Asia, North America, Europe, Rest of World (ROW) - China, US, Germany, Japan, UK - Size and Forecast 2024-2028

Regulatory Affairs Outsourcing Market Size 2024-2028

The regulatory affairs outsourcing market size is forecast to increase by USD 4.71 billion at a CAGR of 12.3% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The expanding pharmaceutical industry and increasing consumption of Class I medical devices are driving the demand for regulatory compliance services. Additionally, companies are offering both stand-alone services and full-scope solutions to cater to various client needs. The market is shifting towards project-based and long-term partnership models, allowing for more flexibility and cost savings. Functional service provision, such as dedicated experts, is becoming increasingly popular as companies seek to uphold regulatory compliance while focusing on their core business operations. Outsourcing solutions are essential for organizations to keep up with the challenges of contractual obligations and the constant need to upgrade new technologies. This trend is expected to continue as regulatory requirements become more complex and the need for expert knowledge and resources grows.

 Request Free Sample

The regulatory affairs outsourcing market refers to the practice of engaging third-party companies to provide stand-alone regulatory services or full-scope solutions for the development, registration, and maintenance of innovative medicines, generics, consumer healthcare products, food supplements, and biotech products. This market has gained significant traction in recent years due to the increasing complexity of regulatory requirements and the need for workload optimization and centralization. One of the primary drivers of the regulatory outsourcing market is the ability to access a dedicated team of regulatory experts without the need for in-house staffing and training. companies offer project-based and long-term partnerships, providing clients with flexibility and scalability to meet their regulatory needs.

These partnerships enable companies to focus on their core competencies while ensuring high-quality services and effective oversight of regulatory affairs. Functional service provision in regulatory affairs includes various activities such as regulatory strategy, regulatory affairs department management, quality and compliance, and life-cycle management. Outsourcing solutions offer numerous benefits, including access to a company network optimized for regulatory expertise, internal resources expertise, and innovation. The regulatory affairs outsourcing market is not limited to pharmaceuticals but also extends to the consumer healthcare products and food supplement industries. companies provide a range of services, from regulatory strategy and compliance to regulatory intelligence and reporting.

Furthermore, the market is expected to grow as companies continue to seek ways to optimize their internal resources and improve the efficiency of their regulatory functions. Centralization of regulatory affairs functions is a key trend in the market, as companies look to streamline their operations and reduce costs. Outsourcing regulatory affairs functions allows companies to leverage the expertise of dedicated companies and focus on their core business activities. Additionally, outsourcing can help ensure regulatory compliance and reduce the risk of non-compliance penalties. The regulatory affairs outsourcing market offers a range of benefits, including workload optimization, centralization, and access to a network of regulatory experts. Companies can choose from project-based or long-term partnerships, depending on their specific needs. The market is expected to continue growing as companies seek to improve the efficiency and effectiveness of their regulatory functions.

In conclusion, the regulatory affairs outsourcing market offers companies a flexible and cost-effective solution for managing their regulatory functions. By engaging third-party companies, companies can access a team of dedicated regulatory experts, optimize their internal resources, and ensure regulatory compliance. The market is expected to continue growing as companies seek to improve the efficiency and effectiveness of their regulatory functions and focus on their core business activities. 

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user
  • Pharmaceutical
  • Medical devices
  • Biotechnology
• Geography
  • Asia
    • China
    • Japan
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Rest of World (ROW)

By End-user Insights

The pharmaceutical segment is estimated to witness significant growth during the forecast period. Pharmaceutical companies in the US seek outsourcing services for regulatory affairs to reduce internal headcount, allocate resources to strategic projects, and enhance the productivity of their existing teams. The regulatory landscape for pharmaceuticals is complex and demanding, necessitating stringent adherence to government regulations and approval processes. 

Get a glance at the market share of various segments Download the PDF Sample

The pharmaceutical segment was valued at USD 1.71 billion in 2018. The regulatory consulting market is experiencing growth due to factors such as process optimization, cost savings, and the utilization of specialized expertise in regulatory affairs. Services offered by regulatory consulting firms encompass various aspects of regulatory compliance, including establishment registration, product listing, pre-market notifications (510(k) or pre-market approval), investigational device exemptions for clinical studies, quality system regulations, labeling requirements, pharmaceutical reporting, product testing, and certification services. These firms handle documentation preparation and submit testing data to the relevant regulatory authorities. By outsourcing regulatory affairs functions, pharmaceutical companies can focus on their core competencies while ensuring regulatory compliance and maintaining a lean, efficient organization.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

Asia is estimated to contribute 49% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The Regulatory Affairs outsourcing market in Asia is experiencing notable expansion over the coming years. This growth can be attributed to the substantial market presence of generic drugs and the increasing utilization of advanced technologies in countries like India and China. Among these, India is projected to be the most rapidly expanding market due to its cost-effectiveness. Currently, China holds the leading position in the Asian market and is anticipated to continue doing so throughout the forecast period. The region's allure is further amplified by its cost advantages compared to Europe and North America. These cost savings stem from the abundant availability of resources, including labor and active pharmaceutical ingredients (APIs), as well as affordable land for establishing manufacturing facilities. Companies in the food supplements industry, particularly those in the biotech sector, can optimize their company networks and internal resources by leveraging the expertise of regulatory affairs departments in Asia. By outsourcing regulatory affairs functions to these regions, firms can ensure high-quality services, compliance, and life-cycle management for their products.

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The growth of pharmaceutical industry is notably driving market growth. The escalating drug pipeline and the resulting increase in product registration and clinical trial application processes are driving the demand for regulatory affairs outsourcing services in the pharmaceutical industry. Pharmaceutical companies typically allocate 15%-20% of their annual revenue towards research and development (R&D). For instance, Biogen and F. Hoffmann-La Roche, two major pharmaceutical manufacturers, spent approximately 18%-20% of their revenue on R&D in 2020. This significant investment in R&D is expected to lead to the introduction of numerous new pharmaceutical products during the forecast period.

Consequently, there is a growing need for regulatory affairs outsourcing services to ensure compliance with safety regulations and manage various regulatory activities, such as pharmacovigilance and operations. company selection is a crucial aspect of regulatory affairs outsourcing, and companies often consider factors like technology expertise and proven track record when choosing a service provider. AI agents and technology are increasingly being employed to streamline regulatory activities and enhance efficiency in regulatory affairs outsourcing. Thus, such factors are driving the growth of the market during the forecast period.

Significant Market Trends

The increasing consumption of Class I medical devices is the key trend in the market. In today's healthcare landscape, the demand for Class I medical devices, such as bandages and examination gloves, is increasing due to their affordability and accessibility. As manufacturers produce these devices in greater numbers, they face heightened regulatory requirements to ensure patient safety and operational efficiency. By partnering with an integrated company for regulatory affairs outsourcing, companies can gain agility and expertise in navigating complex regulatory landscapes.

Further, this approach allows them to focus on their core competencies while benefiting from the latest technology solutions and integrated services. Regulatory compliance is a critical aspect of medical device manufacturing, and an outsourcing partner can help streamline the process and maintain adherence to standards. By outsourcing regulatory affairs, companies can improve operational efficiency, reduce costs, and ensure the timely delivery of compliant devices to the market. Thus, such trends will shape the growth of the market during the forecast period.

Major Market Challenge

The delay in contractual obligations and upgrading new technologies is the major challenge that affects the growth of the market. In the regulatory affairs outsourcing market, human experts play a crucial role in ensuring compliance with regulations and delivering high-quality services. However, inefficiencies and suboptimal results can arise due to various reasons, including contractual delays and external factors beyond the control of the outsourcing provider. These issues can negatively impact on-time delivery and customer satisfaction. Moreover, in the life sciences sector, OEMs require agile and responsive outsourcing partners to keep up with the latest technology and regulations.

However, identifying reliable service providers that can offer combined PV (pharmacovigilance) solutions and adhere to standard operating procedures can be challenging. These technical obstacles can hinder the production process and delay the market entry of specialized products, ultimately impacting the profitability of OEMs. Therefore, it is essential for outsourcing service providers to invest in advanced technologies and maintain a strong commitment to customer needs to mitigate these risks and provide optimal solutions. By doing so, they can build long-term partnerships with OEMs and contribute to the success of the life sciences industry. Hence, the above factors will impede the growth of the market during the forecast period.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Cambridge Regulatory Services - The company offers regulatory affair services for pharmaceutical companies

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• APCER Life Sciences Inc.
• BlueReg Group
• Cambridge Regulatory Services
• Certara Inc.
• Charles River Laboratories International Inc.
• Freyr Software Services
• Genpact Ltd.
• ICON plc
• Laboratory Corp. of America Holdings
• Medpace Holdings Inc.
• NDA Group AB
• Parexel International Corp.
• PHARMALEX GMBH
• ProPharma Group Holdings LLC
• Qvigilance
• Real Regulatory Ltd.
• Thermo Fisher Scientific Inc.
• WuXi AppTec Co. Ltd.
• Zeincro Group

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Regulatory affairs outsourcing has become a popular stand-alone service and full-scope solution for life sciences companies seeking to optimize their operational efficiency and focus on strategic projects. Outsourcing regulatory activities to a company allows in-house staff to offload workload and centralize oversight of quality and compliance. companies offer project-based and long-term partnerships, providing functional service provision for innovative medicines, generics, consumer healthcare products, food supplements, and biotech. These outsourcing solutions enable workload optimization and company network optimization, leveraging the expertise of dedicated experts in regulatory affairs. Quality and compliance are paramount in regulatory affairs, and outsourcing allows companies to access the latest technology solutions and best practices.

Companies provide high-quality services for regulatory activities, including pharmacovigilance, regulatory requirements, and safety. In the emerging biopharma landscape, operational agility is crucial. Integrated company partners offer combined pv solutions, standard operating procedures, and agile services to meet customer needs. Human experts and AI agents work together to ensure optimal results and patient safety. company selection is essential, and companies must consider the company's regulatory expertise, technology solutions, and ability to adapt to evolving regulatory requirements. By partnering with an experienced company, life sciences companies can streamline their regulatory affairs department and focus on their core competencies.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across Asia, North America, Europe, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch